Literature DB >> 2085771

Factors affecting restraint stress-induced potentiation of morphine analgesia.

D J Calcagnetti1, S G Holtzman.   

Abstract

The analgesic effect of opioid drugs is potentiated in rats exposed to restraint stress as compared to unstressed rats. The purpose of the present study was to quantify how the following factors affect morphine-induced analgesia: habituation to restraint versus exposure to restraint for the first time, restraint stress duration, and interval from restraint to analgesic testing. Expts. 1 and 2 generated dose- and time course curves for morphine in rats exposed to one of 3 treatments: no restraint stress (NS), first exposure to 1 or 6 h of restraint (FS), or 5 days of restraint habituation followed by 1 or 6 h of restraint on the test day (HAB). Analgesia was measured by the tail-flick assay. Rats subjected to 1 h of restraint displayed dose- and time-dependent potentiation of morphine-induced antinociception compared to unstressed rats. Given 4.0 mg/kg morphine. FS-treated subjects showed 1.4- and 2.7-fold more potentiation of analgesia than HAB- and NS-treated rats, respectively. Rats restrained for 6 h prior to testing showed significant dose effect for morphine but failed to reveal significant treatment effects. Thus, increasing the duration of restraint from 1 to 6 h attenuated morphine antinociception in FS- and HAB-treated subjects to the level of NS subjects. In Expt. 3, several groups of rats underwent a single 1-h session of restraint at various time intervals prior to injection with morphine (4.0 mg/kg) and tail-flick testing. An unstressed group also receiving morphine served as control.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2085771     DOI: 10.1016/0006-8993(90)90352-c

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

1.  Deficits in neuronal cytochrome P450 activity attenuate opioid analgesia but not opioid side effects.

Authors:  Lindsay B Hough; Julia W Nalwalk; Rachel A Cleary; James G Phillips; Cheng Fang; Weizhu Yang; Xinxin Ding
Journal:  Eur J Pharmacol       Date:  2014-07-22       Impact factor: 4.432

2.  Social and environmental influences on opioid sensitivity in rats: importance of an opioid's relative efficacy at the mu-receptor.

Authors:  Mark A Smith; Kara A Chisholm; Paul A Bryant; Jennifer L Greene; Jacob M McClean; William W Stoops; David L Yancey
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

3.  Restraint Stress Potentiated Morphine Sensitization: Involvement of Dopamine Receptors within the Nucleus Accumbens.

Authors:  Elham Charmchi; Golnaz Faramarzi; Mina Rashvand; Morteza Zendehdel; Abbas Haghparast
Journal:  Neurochem Res       Date:  2021-01-03       Impact factor: 3.996

4.  DNIC-mediated analgesia produced by a supramaximal electrical or a high-dose formalin conditioning stimulus: roles of opioid and alpha2-adrenergic receptors.

Authors:  Yeong-Ray Wen; Chia-Chuan Wang; Geng-Chang Yeh; Sheng-Feng Hsu; Yung-Jen Huang; Yen-Li Li; Wei-Zen Sun
Journal:  J Biomed Sci       Date:  2010-03-19       Impact factor: 8.410

5.  Amelioration of the reduced antinociceptive effect of morphine in the unpredictable chronic mild stress model mice by noradrenalin but not serotonin reuptake inhibitors.

Authors:  Soichiro Ide; Hiroshi Satoyoshi; Masabumi Minami; Masamichi Satoh
Journal:  Mol Pain       Date:  2015-08-11       Impact factor: 3.395

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.